References
Abedon, S. T. Abedon, C. T., Thomas, A. and Mazure, H., 2011, Bacteriophage prehistory, Bacteriophage, vol. 1(3)
Carlton, R. M., 1999, Phage therapy: past history and future prospects, Archivum immunologiae et therapiae experimentalis, vol. 47(5)
Carlton R., Noordman W., Biswas B., De Meester E, Loessner M., 2005, Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application, Regul Toxicol Pharmacol
Carter, J. B. and Saunders, V. A., 2007, Virology – Principles and Applications, John Wiley & Sons, Ltd.
Clark J. R. and March J. B., 2006, Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials, Trends in Biotechnology, vol. 24
Dublanchet, A., 2007, The epic of phage therapy, The Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 18(1)
Ellis, E. L. and Delbruck, M., 1939, The growth of bacteriophage, Journal of General Physiology, vol. 22(3)
Farr, R., Choi, D. S. and Lee, S., 2014, Phage-based nanomaterials for biomedical applications, Acta Biomaterialia, vol. 10
Fruciano, D. E., 2007, Phage as an antimicrobial agent: d’Herelle's heretical theories and their role in the decline of phage prophylaxis in the West, The Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 18(1)
Henein, A., 2013, What are the limitations on the wider therapeutic use of phage?, Bacteriophage.
Li K. et al., 2010, Chemical modification of M13 bacteriophage and its application in cancer cell imaging, Bioconj Chem, vol.21.
Merzlyak A., Indrakanti S. and Lee S. W., 2009, Genetically engineered nanofiber-like viruses for tissue regenerating materials, Nano Lett vol. 9
Periasamy, D. and Sundaram A., 2013, A novel approach for pathogen reduction in wastewater treatment, Journal of Environmental Health Science and Engineering.
Poul M. A. and Marks J. D., 1999, Targeted gene delivery to mammalian cells by filamentous bacteriophage, Journal of Molecular Biology
Stephen T. Abedon, Sarah J. Kuhl, Bob G. Blasdel & Elizabeth Martin Kutter (2011) Phage treatment of human infections, Bacteriophage, 1:2, 66-85
Sulakvelidze A. and Kutter E., 2005, Bacteriophage therapy in humans, Bacteriophages: Biology and Application. Boca Raton, FL: CRC Press, 2005:381-436.
Tortora, G.J., Funke, B. R. and Case, C. L., 2010, Microbiology, 10th ed., Benjamin Cummings
Willey, J. M., Sherwood, L. M. and Woolverton, C. J., 2008, Prescott,Harley, and Klein’s Microbiology, 7th ed., McGraw Hill
Carlton, R. M., 1999, Phage therapy: past history and future prospects, Archivum immunologiae et therapiae experimentalis, vol. 47(5)
Carlton R., Noordman W., Biswas B., De Meester E, Loessner M., 2005, Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application, Regul Toxicol Pharmacol
Carter, J. B. and Saunders, V. A., 2007, Virology – Principles and Applications, John Wiley & Sons, Ltd.
Clark J. R. and March J. B., 2006, Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials, Trends in Biotechnology, vol. 24
Dublanchet, A., 2007, The epic of phage therapy, The Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 18(1)
Ellis, E. L. and Delbruck, M., 1939, The growth of bacteriophage, Journal of General Physiology, vol. 22(3)
Farr, R., Choi, D. S. and Lee, S., 2014, Phage-based nanomaterials for biomedical applications, Acta Biomaterialia, vol. 10
Fruciano, D. E., 2007, Phage as an antimicrobial agent: d’Herelle's heretical theories and their role in the decline of phage prophylaxis in the West, The Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 18(1)
Henein, A., 2013, What are the limitations on the wider therapeutic use of phage?, Bacteriophage.
Li K. et al., 2010, Chemical modification of M13 bacteriophage and its application in cancer cell imaging, Bioconj Chem, vol.21.
Merzlyak A., Indrakanti S. and Lee S. W., 2009, Genetically engineered nanofiber-like viruses for tissue regenerating materials, Nano Lett vol. 9
Periasamy, D. and Sundaram A., 2013, A novel approach for pathogen reduction in wastewater treatment, Journal of Environmental Health Science and Engineering.
Poul M. A. and Marks J. D., 1999, Targeted gene delivery to mammalian cells by filamentous bacteriophage, Journal of Molecular Biology
Stephen T. Abedon, Sarah J. Kuhl, Bob G. Blasdel & Elizabeth Martin Kutter (2011) Phage treatment of human infections, Bacteriophage, 1:2, 66-85
Sulakvelidze A. and Kutter E., 2005, Bacteriophage therapy in humans, Bacteriophages: Biology and Application. Boca Raton, FL: CRC Press, 2005:381-436.
Tortora, G.J., Funke, B. R. and Case, C. L., 2010, Microbiology, 10th ed., Benjamin Cummings
Willey, J. M., Sherwood, L. M. and Woolverton, C. J., 2008, Prescott,Harley, and Klein’s Microbiology, 7th ed., McGraw Hill